R&D, innovation and competitiveness in the European chemical industry
Author(s)
Bibliographic Information
R&D, innovation and competitiveness in the European chemical industry
Kluwer Academic Publishers, c2004
- : hbk
- Other Title
-
R and D, innovation and competitiveness in the European chemical industry
Available at 8 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
R&D, Innovation and Competitiveness in the European Chemical Industry explores the science & technology base and the dynamic performance of the European "system of innovation" in the chemical industry, with particular attention to its contribution to economic growth through innovation and competitiveness, and its ability to translate its research into commercially useful products. It also analyses the forces that encourage the diffusion of chemical innovations on downstream user industries and among large and small firms. The studies presented in this book represent an analysis of the issues and questions raised by the Green Paper on Innovation presented by the European Commission, for the specific case of the European chemical industry.
R&D, Innovation and Competitiveness in the European Chemical Industry will be of interest to industry and government experts related to the chemical industry, scholars; both faculty and graduate students interested in growth, corporate strategy and the management of innovation.
Table of Contents
- Preface. Introduction
- F. Cesaroni, A. Gambardella, W. Garcia-Fontes. 1. Objective. 2. How this book is organised. 3. Policy concerns. 4. References. 1: Market Structure and Innovation. Market structure, competition and innovation in the European and US chemical industries
- P.L. Marin, G. Siotis. 1. Introduction. 2. Theoretical motivation. 3. Data and variables from the chemical industry. 4. Empirical findings. 5. Conclusions. 6. References. Mergers and acquisitions in the chemical industry: similarities and dissimilarities across the Atlantic
- C. Ornaghi, P.L. Marin, G. Siotis. 1. Introduction. 2. Data. 3. Overview of M&As flows. 4. Analysis of investment flows by sector. 5. Diversification strategies. 6. Conclusions. 7. References. Corporate restructuring and R&D: a panel data analysis for the chemical industry
- A. Arora, M. Ceccagnoli, M. Da Rin. 1. Introduction. 2. Data description. 3. R&D and corporate restructuring. 4. Conclusions. 5. References. 2: Technology Development and Diffusion. Watching paint dry? S. Brusoni. 1. Introduction. 2. Some definitions. 3. Industry structure in the 1990s. 4. Innovation: sources, trends and appropriability. 5. Environmentalregulation and innovation. 6. The development of low solvents and solvent-free coatings. 7. The adoption of waterborne formulations. 8. Discussionsand conclusions. 9. References. Research collaborations among inventors and the location of R&D in the European Chemical Industry
- M. Mariani. 1. Introduction. 2. Organisational vs. geographical proximity. 3. Insights from the data. 4. Multiple correlations: probit and OLS regressions. 5. Conclusions. 6. Main references. 7. Annex. Collaboration between a research university and firms and other institutions
- A. Geuna, P. Llerena, M. Matt, M. Savona. 1. Introduction. 2. University-industry relationships: the core topics. 3. ULP contractual relationships. 4. Characteristics of chemistry domain contracts. 5. Entry, exit and persistence of collaboration. 6. Conclusions. 7. References. The nature and extent of the market for technology in biopharmaceuticals
- A. Arora, A. Gambardella, F. Pammolli, M. Riccaboni. 1. Introduction. 2. The sample of drug R&D products. 3. The NBFs as an American phenomenon. 4. 'Risky' projects. 5. Probability of success: licensed vs. in-house products. 6. Assessing development capabilities. 7. Assessing the originators capabilities. 8. Failing at earlier stages. 9. Conclusions. 10. Appendix. 11. References. 3: Policy Regulation an
by "Nielsen BookData"